Bickerstaff George sold $926K of CDNA
Bickerstaff George sold 20,000 shares of CareDx, Inc. (CDNA) at $46.28 ($0.93M total) on 2026-08-05.
How this was made
The 30-second read
Why it matters
The newest fact is the director’s open-market sale of 20,000 shares at a stated price, with post-transaction holdings reported.
Market read
Traders may monitor insider activity, but this filing alone does not change the company’s outlook.
What to watch
Insider sales can be driven by diversification, taxes, or pre-existing personal liquidity needs; without additional context, signal quality is low.
Background
The article is an SEC Form 4 insider transaction disclosure for CareDx, Inc. (CDNA).
Ticker impact
CareDx director Bickerstaff George filed a Form 4 selling 20,000 shares at $46.2850 on 2026-08-05, totaling about $925.7K.
Likely limited near-term impact; any effect is more sentiment/flow than a fundamental catalyst.
Form 4 insider sales are common and often non-informational; the filing provides transaction details but no accompanying company-specific news or guidance change.
Market effects
No clear sector read-through from a single director sale.
None indicated.
None indicated.
Counterpoint
Absence of a 10b5-1 plan could be interpreted by some traders as less routine, potentially increasing short-term skepticism.
Key entities
- issuerCareDx, Inc.
Subject of the Form 4 insider transaction disclosure (CDNA).
- insiderBickerstaff George
Director who sold 20,000 shares in an open-market transaction.
